Leslie Kean is an Oncology physician affiliated with Boston Children's Hospital. OpenAlex indexes 315 publications with 9,205 citations (h-index 46); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Longwood Ave
Boston, MA 021155724
Telephone
617-355-6000Registry record last updated 7 Jan 2019.
Clinical trials
- Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)
Sponsor: Boston Children's Hospital
- Abatacept as GVHD Prophylaxis Phase 2
Sponsor: Boston Children's Hospital
- Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
Sponsor: Boston Children's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year202512 payments$147,695openpaymentsdata.cms.gov ↗
- National Marrow Donor ProgramProgram year20252 payments
- Syndax Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
7 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- Optimizing HCT Outcomes: A Multi-omic Investigation
Boston Children'S Hospital
FY2026$1,913,626R01HL181969 - Project 2: The New Era of Cellular Therapies For Lung Transplant Tolerance
Massachusetts General Hospital
FY2026$680,368U19AI174967
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
New England Journal of Medicine
2025 - Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
New England Journal of Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Stuart Orkin, MD
Boston Children's Hospital
Jane Newburger, MD
Boston Children's Hospital
Michael Landzberg, MD
Boston Children's Hospital
Stephen Sallan, MD
Boston Children's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”